임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
60건 표시 (상위 60건)
- 1/2상모집 중· Tetanus-diphtheria-acellular Pertussis (Tdap)A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
리드: GC녹십자
- 1/2상모집 중· Fabry DisesaseA proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
리드: GC녹십자 · 협력: 한미약품
- 1상모집 중· Sanfilippo Syndrome Type APhase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
리드: GC녹십자
- 단계 미표기모집 중단 (진행 중)· Hypertension, DyslipidemiaEvaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study
리드: GC녹십자
- 1상상태 미확인· Healthy VolunteersA Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions
리드: GC녹십자
- 해당없음상태 미확인· Varicella Zoster Virus InfectionAn Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years
리드: GC녹십자
- 1상상태 미확인· Healthy VolunteersA Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fasting Conditions
리드: GC녹십자
- 1상모집 중단 (진행 중)· Mucopolysaccharidosis IIA Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ
리드: GC녹십자
- 해당없음완료· Respiratory SymptomsGCWB1001 Evaluates the Effectiveness and Safety of Respiratory Health
리드: GC녹십자
- 3상모집 중단 (진행 중)· Primary Immune DeficiencyStudy of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
리드: GC녹십자
- 2상상태 미확인· Urachal CancerA Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer
협력: GC녹십자
- 2상완료· Autoimmune EncephalitisSafety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:
리드: GC녹십자
- 2상상태 미확인· TetanusA Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
리드: GC녹십자
- 3상철회· Primary Immune Deficiency DisorderStudy of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency
리드: GC녹십자
- 2상상태 미확인· Hepatitis BA Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
리드: GC녹십자
- 4상완료· Kawasaki DiseaseStudy of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
리드: GC녹십자
- 4상완료· Renal TransplantIVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies
협력: GC녹십자
- 1상완료· Herpes ZosterSafety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects
협력: GC녹십자
- 2상완료· Influenza, HumanA Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects
리드: GC녹십자
- 해당없음상태 미확인· Thyroid Gland CarcinomaEffect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery
협력: GC녹십자
- 1/2상완료· Metastatic Colorectal CancerA Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
리드: GC녹십자
- 2/3상상태 미확인· Hepatitis B InfectionHBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
리드: GC녹십자
- 1상상태 미확인· TuberculosisStudy to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults
리드: GC녹십자
- 1상완료· Influenza, HumanA Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults
리드: GC녹십자
- 3상상태 미확인· Influenza VaccineA Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age
리드: GC녹십자
- 3상완료· Influenza, HumanA Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older
리드: GC녹십자
- 3상상태 미확인· Influenza, HumanA Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults
리드: GC녹십자
- 3상완료· Immunologic Deficiency SyndromesStudy of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
리드: GC녹십자
- 1/2상상태 미확인· TetanusSafety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
리드: GC녹십자
- 1상완료· Chronic Hepatitis BA Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
리드: GC녹십자
- 3상상태 미확인· HealthyStudy to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult
리드: GC녹십자
- 4상완료· Influenza, HumanEvaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old
협력: GC녹십자
- 3상완료· InfluenzaA Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children
리드: GC녹십자
- 1상완료· Varicella (Chicken Pox)Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults
리드: GC녹십자
- 2상완료· Hepatitis B InfectionA Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients
리드: GC녹십자
- 1상상태 미확인· Neoplasm MetastasisSafety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
리드: GC녹십자
- 2상상태 미확인· GastritisPhase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
리드: GC녹십자
- 해당없음완료· Helicobacter Pylori InfectionCompare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
협력: 종근당, GC녹십자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.